Dexcom G5 price plan for existing customers

Do you self-fund a Dexcom G5? Their new subscription plan for existing customers could save you money!

For £160 per month you will get 4 x transmitters and 28 sensors.

Have a look at the various options by clicking on the link below

Dexcom G5 Price Plan Nov 2017 UK

Posted in Product announcements | Tagged , | Comments Off on Dexcom G5 price plan for existing customers

Market research: -All spaces now filled- Animas pump users, £150 incentive, UK

Market research opportunity:
Animas pump users  – £150 incentive for 30 minutes reading and 60 minute phone interview. Anywhere in UK.

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

 

Creative Medical Research are looking for 10 Animas pump users (adults or parents of a child on an Animas pump).

You will need to be available to talk on the phone on Tuesday 28 November or Wednesday 29 November (day time or evening) and you will need to be prepared to do 30 minutes of reading before their interview.

For 30 minutes reading and 60 minute phone call you will receive £150 for taking part.

ALL SPACES NOW FILLED – SORRY!

 

 

Posted in Market research | Comments Off on Market research: -All spaces now filled- Animas pump users, £150 incentive, UK

i-Port Advance injection port for MDI users

Medtronic are celebrating World Diabetes Day!

i-Port Advance™ is now available at a discounted price for a limited time only – offer ends 28 November 2017

How many times do you inject over 3 days?
Would you like to reduce that to one single skin puncture?

i-Port Advance is a small injection port that lets you take your insulin without having to puncture your skin for each injection. It’s easy to wear and easy to use, and both fast and long acting insulin can be injected into the same port. The port can be worn for up to three days during all normal activities, including sleeping, bathing and exercise.

 

 

Normally £72 online (ex VAT) for a box of 10 (1 month supply), from today until 28 November 2017 you can get a box of 10 for just £60 – the same price as at select Paydens pharmacies in the South East. Note this is currently not normally available on the NHS.

To find out more and take advantage of this offer click here

It won’t hurt to try…

What are the benefits?

iPort Advance™ has been proven to:

  • Reduce Pain
  • Reduce Anxiety
  • Improve quality of life

99% of patients report that i-Port Advance™ is beneficial
98% of patients think that i-Port Advance™ is comfortable to wear

What do patients say about i-Port Advance™?

“There were times before when diabetes restricted me. Parents would bring snacks and food to rehearsals and tennis matches, but I wouldn’t eat them because I didn’t want to take extra injections. Now, with i-Port Advance I can enjoy the food because I don’t mind taking the extra dose, and I feel just like any other teen in the room!”
Lindsey, age 16, has type 1 diabetes

To find out more and take advantage of this offer click here

Posted in Product announcements | Tagged , , | Comments Off on i-Port Advance injection port for MDI users

Market research: Adults or parents of children with type 1 diabetes: Chester, Glasgow, London

Market research opportunity:
Adults with type 1 diabetes or parents of children with type 1 diabetes – £60 incentive for 90 minute interview in your own home. Chester, Glasgow and London

 

 

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

Acumen Healthcare are currently looking to speak with:

  • adults with type 1 diabetes
  • parents of children with type 1 diabetes

to take part in a 90 minute in-home interview in Chester or Glasgow to  better understand your day to day living with your condition.

The interviews will take place from Monday 20 – Wednesday 22 November at a time convenient to you.

They are also looking for just one parent in London to take part in an in-home interview on Thursday 16 November

If you are interested, please click here to apply. Don’t forget to mention INPUT!

Anyone taking part will receive £60 as a thank you for their time

Posted in Market research | Comments Off on Market research: Adults or parents of children with type 1 diabetes: Chester, Glasgow, London

Market research: T1D insulin pump users, 12-adult, Birmingham

Market research opportunity:
Pump users – £80 incentive for 75 minute interview in London

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

 

The Research House are looking to speak with people who have been diagnosed with type 1 diabetes who currently use an insulin pump, to take part in a 75 minute research interview on how T1D and using a pump impacts their day to day lives. The study is open to anyone aged 12 and up, including adults. Those aged 12 – 17 will need to attend with a parent/responsible adult.

For taking part in this research you would receive £80 as a thank you.  The research is taking place in Edgbaston, Birmingham on 8, 9 and 10 November.

If you are interested please contact Robert Thomas on 0207 487 9223 or email him on Robert.Thomas@schlesingerassociates.com to see if you quality for the study. Don’t forget to mention INPUT!

The Research House’s flyer about this project

 

Posted in Market research | Comments Off on Market research: T1D insulin pump users, 12-adult, Birmingham

Market research: T1D insulin pump users, 12-adult, London

Market research opportunity:
Pump users – £80 incentive for 75 minute interview in London

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

 

The Research House are looking to speak with people who have been diagnosed with type 1 diabetes who currently use an insulin pump, to take part in a 75 minute research interview on how T1D and using a pump impacts their day to day lives. The study is open to anyone aged 12 and up, including adults. Those aged 12 – 17 will need to attend with a parent/responsible adult.

For taking part in this research you would receive £80 as a thank you.  The research is taking place in central London.

If you are interested please contact Robert Thomas on 0207 487 9223 or email him on Robert.Thomas@schlesingerassociates.com to see if you quality for the study. Don’t forget to mention INPUT!

The Research House’s flyer about this project: MR24Oct

 

Posted in Market research | Comments Off on Market research: T1D insulin pump users, 12-adult, London

Access to Flash Glucose Monitoring (Flash GM)

Diabetes UK, INPUT and JDRF believe that Flash GM devices should be made available to any adult or child with type 1 diabetes, and to people with other forms of diabetes when intensive insulin therapy becomes necessary as outlined in our guideline.

Following campaigning across the diabetes community, from 1st November 2017 Flash GM will be made available on the NHS Drugs Tariff. This means in principle it is available to people with diabetes on NHS prescription.

It will now be up to local decision makers to draw-up policies about who can access the technology and in what ways.

Guidance on these local policies will come from specialists within the NHS and the final decisions on access will be made by local health decision makers.

Diabetes UK, INPUT and JDRF will work together to:

  • Ensure that the voices of people with diabetes are heard, and that their needs are forefront in decision-making.
  • Seek solutions to address barriers to access locally and nationally as they occur.
  • Inform people with diabetes about access and support people to know their rights.

We will continue to work together until those who would benefit and like to use Flash GM can easily and simply access it on the NHS.

Posted in News | Tagged | Comments Off on Access to Flash Glucose Monitoring (Flash GM)

Market research: T1D insulin pump users, Manchester

Market research opportunity:
Pump users – £80 incentive for 75 minute interview in Manchester

When our posts help to recruit participants for market research we earn a finder’s fee. These fees help with our running costs. By taking part or sharing our posts, you are helping to raise vital income for INPUT. Thank you!

 

Acumen Healthcare are looking to speak with people who have been diagnosed with type 1 diabetes who currently use an insulin pump, to take part in a 75 minute research session.

For taking part in this research you would receive £80 as a thank you. Sessions are between Monday 13th November and Thursday 16th November and they have various times available. The research is taking place in central Manchester (M1).

If you are interested please follow the link below to apply – and mention INPUT!
www.healthcareopinions.co.uk/projects/manchester/diabetes-5/

Posted in Market research | Comments Off on Market research: T1D insulin pump users, Manchester

New OneTouch Reveal mobile app

Press release by OneTouch on 12 September 2017

New OneTouch Reveal® Mobile App Empowers People with Diabetes to Manage their Blood Sugar and Easily Connects them with their Diabetes Care Support Network

Easy-to-use interconnected diabetes management system changes the way patients see their blood sugar readings and enables healthcare professionals, family, and friends to help them manage their condition

The new OneTouch Reveal® mobile app is now available in the UK and Ireland. It includes innovative, user-inspired features including blood sugar and activity timelines transformed into quick visual snapshots which allow people with diabetes to see their results, identify trends and get on with their daily life.

The new version of the OneTouch Reveal® mobile app has been designed to help patient engagement. It has an easy to use interface that changes the way patients see their blood sugar and manage their diabetes. In addition to the timeline and visual logbook, new features include a fingerprint login, an events newsfeed featuring relevant articles, a reminder function, averages for 14-, 30-, or 90- day time periods, and a break out of pre- and post-meal tagged results. The OneTouch Reveal® mobile app also uses ColorSure™ technology, which highlights patterns that show users a bigger picture.

 

Dr Iain Cranston, Consultant Physician at Portsmouth Hospitals NHS Trust said, “It is important that people with diabetes who test their blood sugar levels regularly are able to utilise the information from such tests to adjust therapies which may help with better overall control. Modern meters and apps (such as OneTouch Reveal®) which allow patients to easily assess patterns are thus an important part of this progressive process of improvement.”

 

The OneTouch Reveal® mobile app is the central component of the OneTouch® circle of support that connects patients to resources beyond devices. The OneTouch Reveal® mobile app seamlessly syncs with the OneTouch Verio Flex® blood glucose monitoring (BGM) system with built-in Bluetooth® Smart Technology. This connectivity enables users to see their blood glucose readings on the mobile app on their smart device and on their computer through the OneTouch Reveal® web app, and also makes it easier than ever for patients to share their data with their healthcare teams so that the teams can see their progress.

 

Chris Aldred, aka The Grumpy Pumper has been trying out the OneTouch Reveal® mobile app. He said “I’m not one for logging my data or messing about with cables for uploading it, I’ve got a life to live and it’s not going to be slowed down by my Diabetes. So at the times I do want to log my data, such as annual review time, being able to Bluetooth it across to the app is really useful.”

Martin Lambert, Head of Marketing UK&I, Johnson and Johnson Diabetes Care Companies (makers of OneTouch® products) said “We are delighted to launch the new OneTouch Reveal® mobile app and digital platform. We have designed the new interface with engaging social networking apps in mind, to appeal both to people with diabetes who are new to digital diabetes apps, as well as those who are more familiar with their use. Enhanced connectivity and the new user experience to help people with diabetes to quickly see and check their results, allowing them to make meaningful decisions and take an active role in their diabetes management.”

With more than 312,000 total downloads and 34 million plus blood glucose readings, the OneTouch Reveal® mobile app is one of the top downloaded diabetes apps globally.[1] In a clinical study, eight out of 10 people who had used the OneTouch Reveal® mobile app agreed that it helped them to better manage their blood glucose.[2]

About Johnson & Johnson Diabetes Care Companies (JJDCC)

With a shared vision of creating a world without limits for people with diabetes, the Johnson & Johnson Diabetes Care Companies are a collaboration of Johnson & Johnson companies dedicated to diabetes and includes LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of innovative insulin delivery systems; Calibra Medical, Inc. developer of OneTouch Via™ on-demand insulin delivery; and the Johnson & Johnson Diabetes Institute, LLC, a global initiative to improve care and better outcomes worldwide through education and training programs. In the U.S., LifeScan, Inc. is the leading blood glucose monitoring company and OneTouch® brand products are recommended by more endocrinologists and primary care physicians than any other brand.[3] Globally, more than 20 million people depend on OneTouch® brand products to help them manage their diabetes. For more information, visit: www.myOneTouch.co.uk

 

Posted in Product announcements | Comments Off on New OneTouch Reveal mobile app

Patient representatives needed for Kent, Sussex & Surrey Diabetes Technology Collaborative

INPUT is delighted to be part of a type 1 diabetes adult service improvement project in Kent, Sussex & Surrey. Aimed at improving access to technology and reducing variation in access across the region, this 2 year project will be launched in October 2017.

The project is looking for 10 patient representatives (adult clinics) from across the region, who use insulin pumps or CGM and have experience of receiving care with their local team. If you transferred to a London clinic in order to access pump therapy you would also be welcome as long as you still live in the KSS area.

It is hoped that patient representatives will be joined up with their local Trust team during the 4 quality improvement workshop events where the Trust teams would be reviewing why in their service patients are experiencing difficulty in accessing medical technology and how access can be improved.

Patient representatives will need to commit to attend all 4 workshop days, to be held in the KSS region, and the workshops will run from around 9am to 4:30pm.

The workshop event days are

Workshop 1, Wednesday, 18 October 2017

Workshop 2, 28th February 2018

Workshop 3, 13th June 2018

Workshop 4, 19th September 2018

If you would like to be considered, please email
kssahsn.diabetes@nhs.net

Posted in Service improvement | Comments Off on Patient representatives needed for Kent, Sussex & Surrey Diabetes Technology Collaborative